| | | | |
| | | | |
CUSIP No. 366505105 | | | | Page 23 of 28 Pages |
Item 1. Security and Issuer.
This Amendment No. 1 amends the Schedule 13D filed on May 14, 2021 (the “Schedule 13D”). The class of equity securities to which this Schedule 13D relates is the common stock, par value $0.001 per share (the “Common Stock”), including shares of Common Stock issuable upon conversion of shares of Series A Preferred Stock, of Garrett Motion Inc., a Delaware corporation (the “Company”). According to the Company, the address of its principal executive office is La Pièce 16 Rolle, Switzerland 1180. Unless specifically amended hereby, the disclosures set forth in the Schedule 13D remain unchanged. Capitalized terms used but not otherwise defined herein have the meanings given to them in the Schedule 13D.
Item 2. Identity and Background.
Item 2 (a)-(c), (f) of the Schedule 13D is hereby amended and supplemented by adding the following as Reporting Persons:
Oaktree Opportunities Fund Xb Holdings (Delaware), L.P., a Delaware limited partnership (“Xb Holdings”), whose principal business is to act as a special purpose holding vehicle for securities, loans, private equity and other assets with a focus on distressed opportunities, in its capacity as the direct owner of 2,874,489 shares of Common Stock.
Brookfield Asset Management ULC, a British Columbia corporation, whose principal business is to serve as a holding company with respect to the global alternative asset management business including those conducted by Oaktree Capital Management, L.P., in its capacity as the indirect owner of class A units of Atlas. This entity is jointly held by Brookfield Corporation and Brookfield Asset Management Limited with each holding a 75% and 25% interest respectively.
Oaktree Phoenix Investment Fund GP, L.P., a Cayman Island limited partnership, whose principal business is to serve as, and perform the functions of, the general partner of Phoenix, in its capacity such.
Oaktree Phoenix Investment Fund GP Ltd., a Cayman Island exempted company, whose principal business is to serve as, and perform the functions of, the general partner of Phoenix, in its capacity such.
Annex A to the Schedule 13D is hereby amended to include the following:
Oaktree Opportunities Fund Xb Holdings (Delaware), L.P.
The general partner of Oaktree Opportunities Fund Xb Holdings (Delaware), L.P. is Oaktree Fund GP, LLC.
Brookfield Asset Management ULC
Brookfield Asset Management ULC is controlled by its board of directors.
Oaktree Phoenix Investment Fund GP, L.P.
The general partner of Oaktree Phoenix Investment Fund GP, L.P. is Oaktree Phoenix Investment Fund GP Ltd.
Oaktree Phoenix Investment Fund GP Ltd.
Oaktree Capital Management, L.P. is the director of Oaktree Phoenix Investment Fund GP Ltd.
Item 3. Source and Amount of Funds or Other Consideration.
2,874,489 shares of Common Stock acquired upon effectiveness of the Plan and previously attributed to OCM Opps GTM Holdings LLC (“GTM Holdings”), a subsidiary of Xb Holdings, are held of record by Xb Holdings.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is hereby amended to include the following:
On April 12, 2023, the Company entered into a Transaction Agreement (the “Transaction Agreement”) with Oaktree Value Opportunities Fund Holdings, L.P., GTM Holdings, Oaktree Phoenix Investment Fund LP and Xb Holdings (collectively, the “Investors”). The Transaction Agreement contemplates, among other things, the repurchase of approximately $290 million of Series A Preferred Stock from the Investors holding Series A Preferred Stock (the “Series A Repurchase”). The Company will pay to Oaktree a cash price of $8.10 per repurchased share, which amount will be adjusted to equal the volume-weighted average price of the Company’s Common Stock for the fifteen trading days following the announcement of the transactions, subject to a minimum price of $7.875 and a maximum price of $8.50. In addition, the Investors will receive certain dividends and other amounts paid or payable with respect to the shares of Series A Preferred Stock, as set forth in the Transaction Agreement and the Second Amended and Restated Certificate of Designations (defined below) in connection with the Series A Repurchase and the Conversion (defined below).
Further, in accordance with the Transaction Agreement, the Investors have delivered to the Company an irrevocable written consent approving and adopting an amendment and restatement to the current certificate of designations for the Series A Preferred Stock (as so amended and restated, the “Second Amended and Restated Certificate of Designations”), providing that all shares of Series A Preferred Stock not repurchased by the Company will convert into shares of Common Stock (the “Conversion”). Upon the Conversion, each holder of Series A Preferred Stock as of the Conversion will receive one share of Common Stock for each share of Series A Preferred Stock then held, plus certain dividends and other amounts paid or payable with respect to the shares of Series A Preferred Stock, as set forth in the Second Amended and Restated Certificate of Designations.
Pursuant to the Transaction Agreement, the Investors have agreed to limit their existing board designation rights from three to one designee. This number will be reduced to zero at such time as the Investors and their affiliates beneficially own less than 10% of the outstanding shares of voting securities of the Company on an as-converted basis. Further, the Investors and their controlled affiliates are subject to certain limitations on their investor rights, which include, among other things, an agreement (i) not to acquire beneficial ownership of additional shares of the Company’s equity securities if it would result in the Investors, together with their controlled affiliates, beneficially owning more than 15% of the outstanding voting securities of the Company on an as-converted basis, and (ii) to vote any shares held in excess of 18% in the manner voted by holders who beneficially own less than 18% of the Company’s voting securities. These limitations will terminate on the earliest to occur of (i) eighteen months from the date of the Transaction Agreements, (ii) the commencement of an unsolicited tender offer for a majority of the voting securities of the Company, or (iii) any insolvency or bankruptcy of the Company.
The Transaction Agreement restricts the Investors from (i) directly or indirectly transferring or disposing of any of their shares, (ii) entering into certain transactions that transfer or dispose of their economic or other interests in such shares, or (iii) publicly disclosing any intention to do either of the foregoing. The lock-up restrictions will be released with respect to 50% of the shares beneficially owned by the Investors and affiliates on the date that is six months from the earlier to occur of (x) the completion of the Series A Repurchases and (y) 45 days from the execution of the Transaction Agreement (the “Lock-Up Trigger Date”), and with respect to all of the shares beneficially owned by the Investors and its affiliates on the date that is twelve months from the Lock-Up Trigger Date. The lock-up restrictions are subject to exceptions, including transfers made with the prior written consent of the Company and the approval of an independent committee consisting of members of the Company’s board of directors who are disinterested with respect to the Company’s Series A Preferred Stock, and customary exceptions for transfers in connections with tender offers, certain other fundamental transactions, and the grant of proxies in connection with annual or special meetings of the Company. The Transaction Agreement may be terminated upon the occurrence of certain events set forth in the Transaction Agreement.
The foregoing description of the Transaction Agreement is a summary only and is qualified in its entirety by the terms and conditions of the Transaction Agreement, which is filed as Exhibit 10.2 attached to the Company’s Form 8-K, filed on April 14, 2023, and incorporated herein by reference.